Showing 6321-6330 of 7932 results for "".
- New Research Explores Nanotechnology as a Vehicle for Delivering Cannabinoids in Dermatologyhttps://practicaldermatology.com/news/new-research-explores-nanotechnology-as-a-vehicle-for-delivering-cannabinoids-in-dermatology/2460849/Nanotechnology delivery systems may be an innovative and effective approach to delivering cannabinoids for skin care, according to a team from the Department of Dermatology at the George Washington University School of Medicine and Health Sciences in Washington, DC. Research fellow Naga
- Study: Skin Reactions After COVID-19 Vaccines Are Rarehttps://practicaldermatology.com/news/study-skin-reactions-after-covid-19-vaccines-are-rare/2460848/Skin problems such as itchiness, rashes, hives and swelling can occur in some individuals after receiving a COVID-19 vaccine, but new research suggests that these reactions are rare, and that even when they do occur with an initial COVID-19 vaccination, they seldom recur after receiving a second
- Foods High in Sugar and Fat Disrupt the Gut Microbiome and Trigger Psoriasis Flareshttps://practicaldermatology.com/news/foods-high-in-sugar-and-fat-disrupt-the-gut-microbiome-and-trigger-psoriasis-flares/2460846/Diets rich in sugar and fat may lead to an imbalance in the gut’s microbial culture and contribute to inflammatory skin diseases such as psoriasis, according to a new study in the Journal o
- Chicago Area Shade Structures to be Dedicatedhttps://practicaldermatology.com/news/chicago-area-shade-structures-to-be-dedicated/2460844/The Deerfield Park District on Monday dedicates Shade Structures installed at Jewett Park Preschool Playground. Len Kasper, the radio play-by-play announcer for the Chicago White Sox, leads the dedication and will share his personal messa
- DermTech Fills Three Leadership Postshttps://practicaldermatology.com/news/dermtech-fills-three-leadership-posts/2460843/With three new appointments, DermTech has filled key leadership roles at the company. Loren Clarke, MD is now Chief Medical Officer, Ray Bassi is Vice President, Sales, and Patrick Johnson is Vice President, Information Technology and Digital Systems. Dr. Clarke, a board-ce
- FDA Approves StrataGraft for the Treatment of Adults with Thermal Burnshttps://practicaldermatology.com/news/fda-approves-stratagraft-for-the-treatment-of-adults-with-thermal-burns/2460839/The U.S. Food and Drug Administration approved StrataGraft for the treatment of adult deep partial thickness burns. "Serious burns can be an incredibly difficult injury to treat and can adversely affect more than just the skin. The goal of burn management is to help the patient ret
- Nutrafol Launches Postpartum Formulahttps://practicaldermatology.com/news/nutrafol-launches-postpartum-formula/2460838/The first-of-its-kind postpartum hair nutraceutical is now available from Nutrafol. Nutrafol Postpartum was developed with an OB/GYN to target the root causes of excess hair shedding and thinning post-pregnancy. It is intended to help the body recover from the physical stress of childbirth,
- Nurx Adds Rosacea Care to List of Serviceshttps://practicaldermatology.com/news/nurx-adds-rosacea-care-to-list-of-services/2460832/Nurx, now includes rosacea treatment in its at-home dermatology services. The service consists of a consultation with a Nurx medical provider, a personalized treatment plan for rosacea, home delivery of medication, and ongoing care. The expansion builds on the successful launch of Nurx&
- EULAR: Data Show Benefit of Tremfya in PsA After Anti-TNF Failurehttps://practicaldermatology.com/news/eular-day-shown-benefit-of-tremfya-in-psa-after-anti-tnf-failure/2460834/New efficacy and safety data presented at the EULAR E-Congress suggest that first-in-class Tremfy (guselkumab) benefits adult patients with active PsA who had inadequate response or intolerance to TNF inhibitors. Trem
- Can Blocking the Function of the CCR6 Chemokine Help Treat Psoriasis and Psoriatic Arthritis?https://practicaldermatology.com/news/can-blocking-the-function-of-the-ccr6-chemokine-help-treat-psoriasis-and-psoriatic-arthritis/2460825/A novel chemical blocker targeting chemokine proteins may significantly reduce skin and joint inflammation in psoriasis and psoriatic arthritis, according to a study in mice. Chemokines are small molecules with a critical role in the body’s response to inflammation and infection.